News|Articles|May 15, 2017
- Pharmaceutical Technology-05-15-2017
- Volume 2017 eBook
- Issue 1
Getting Biopharmaceutical Tech Transfer Right the First Time
Author(s)Agnes Shanley
Good project management, budgeting, planning, and clear documentation are the only ways to prevent overruns and project failure.
Advertisement
Biopharmaceutical experts Stephen Perry, CEO of Kymanox, James Blackwell, principal consultant with The Windshire Group, and consultant Mike Ultee, share best practices and musts to avoid in biopharmaceutical technology transfer.
Some crucial takeaways? Share all data (especially data on failed runs in the past), and include clear instructions for sampling. In addition, aim for reproducibility.
Download
.
Articles in this issue
about 9 years ago
Clean, Disinfect, and Validateabout 9 years ago
Kill the Bioburden, Not the Biological Indicatorabout 9 years ago
Ensuring the Biological Integrity of Raw Materialsabout 9 years ago
Case Study: Retrofitting Two New High-Purity Water Systemsabout 9 years ago
Single-Use Bioreactors Have Reached the Big Timeabout 9 years ago
Parallel Processingabout 9 years ago
Cost Considerations Drive Lean Technology in BiomanufacturingAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Everything to Know about BMS & NVidia’s AI Supercomputer
3
Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs
4
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
5